Seiichiro Mitani

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Metastatic Colorectal Cancer

Mitochondrial Dna

Radiation Therapy

Top Venues

JCO precision oncology

Journal of clinical medicine

Therapeutic advances in medical oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Seiichiro Mitani, Ken Kato, Hiroyuki Daiko, Yoshinori Ito, Isao Nozaki, Takashi Kojima, Masahiko Yano, Satoru Nakagawa, Masaki Ueno, Masaya Watanabe, Shigeru Tsunoda, Tetsuya Abe, Shigenori Kadowaki, Tomohiro Kadota, Keita Sasaki, Ryunosuke Machida, Yuko Kitagawa
Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502. Journal of gastroenterology 57 (7) (2022)
Kaori Hino, Tomohiro Nishina, Takeshi Kajiwara, Hideaki Bando, Maho Nakamura, Shigenori Kadowaki, Keiko Minashi, Satoshi Yuki, Takashi Ohta, Hiroki Hara, Takuro Mizukami, Toshikazu Moriwaki, Koushiro Ohtsubo, Masato Komoda, Seiichiro Mitani, Fumio Nagashima, Ken Kato, Takanobu Yamada, Hiroko Hasegawa, Kentaro Yamazaki, Takayuki Yoshino, Ichinosuke Hyodo
Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2-Positive Esophagogastric and Gastric Cancer. JCO precision oncology 6 (2022)
Kenta Tsunekuni, Hiasto Kawakami, Kazuaki Matsuoka, Hideki Nagase, Seiichiro Mitani, Kazuhiko Nakagawa
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model. Journal of clinical medicine 9 (12) (2020)
Seiichiro Mitani, Hiroya Taniguchi, Keiji Sugiyama, Toshiki Masuishi, Kazunori Honda, Yukiya Narita, Shigenori Kadowaki, Takashi Ura, Masashi Ando, Masahiro Tajika, Yasushi Yatabe, Kei Muro
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation. Therapeutic advances in medical oncology 11 (2019)
Seiichiro Mitani, Shigenori Kadowaki, Isao Oze, Toshiki Masuishi, Yukiya Narita, Hideaki Bando, Sachiyo Oonishi, Yutaka Hirayama, Tsutomu Tanaka, Masahiro Tajika, Yutaro Koide, Takeshi Kodaira, Tetsuya Abe, Kei Muro
Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis. Cancer medicine 9 (1) (2019)